According to a market report, published by Sheer Analytics and Insights, the global allergy diagnostics market was valued at $5.3 billion in 2021 and it is expected to reach $15.5 billion at a CAGR of 7.2% between 2022 and 2032. The main risk factors for developing chronic respiratory disorders include occupational exposure, allergen exposure, and exposure to indoor and outdoor air pollution. Due to greater exposure to environmental contaminants in cities as a result of traffic pollution and industrial activities, the prevalence of allergy disorders among the urban population is higher than that of the population in rural areas. Additionally, as air pollution from automobiles has been identified as one of the key risk factors for allergic disorders, this is a significant indicator for the development of the market for allergy diagnostics. To prevent the spread of viruses in cases of patients with severe asthma or other allergic reactions, virtual care and constrained visitation strategies were used. A key component of diagnostic services is the quick identification and diagnosis of allergic molecules. The development of a completely automated immunoassay system will speed up and increase the efficacy of in-vitro tests for allergen molecules. These primary factors are driving the growth of the market over the past few years.
Furthermore, the market is expected to expand greatly in the next years as hospitals and diagnostic laboratories increasingly turn to automated allergy diagnostics due to their high efficacy. The United States and Canada are probably going to present a lot of highly advantageous opportunities, which will help the market growth overall. As a result, the user-friendly interface and simplicity of use are encouraging home users to use allergy diagnosis. By enhancing their supply chain channels, market players are attempting to make them easily accessible on the market, which will fuel additional market expansion for allergy diagnostics. These major factors would be expected to drive the market during the forecast period.
Request a free PDF sample report: https://www.sheeranalyticsandinsights.com/request-sample/allergy-diagnostics-market-21
Moreover, the development of affordable at-home food allergy and sensitivity testing will spur market expansion in the years to come. These applications will ease the strain on hospitals and labs, which will result in lower allergy diagnostic and treatment costs. There are currently just a few mHealth tools for diagnosing allergic rhinitis (AR) that have been published in peer-reviewed publications, which limits the use of mHealth for the diagnosis of rhinitis. A new breed of point-of-care devices is produced by recent advancements in integrated biosensors, wireless communication, and power harvesting techniques. Therefore, this would create more growth opportunities for the market in the future. Additionally, the market demand will increase with increased innovation among industry participants toward the development of rapid response allergy diagnostic kits.
The Indian market for allergy diagnostics is anticipated to expand rapidly during the projection. According to information from the National Health Portal of India, at least one type of allergy affects 20% to 30% of the country's population. However, Limited income and the high cost of medicines are the key issues restricting the market growth in India. The country's lack of super-specialist training programs in allergy and immunology, as well as the shortage of qualified experts and allergy specialists, are negatively hurting market growth.
To acquire a competitive edge, the majority of industry participants concentrate on developing cutting-edge products and technologies. In the upcoming years, it is anticipated that the introduction of technologically improved products, such as the MeDALL allergen chip for allergy assessment, will further fuel market expansion.
Some new developments in the global allergy diagnostics market:
- On 12th July, 2022, rapid-response laboratory testing of the highest caliber is offered at competitive pricing by Jerath Path Labs and Allergy Testing Centers. One of the most sought-after pathology centers, this one-of-a-kind lab is able to identify all types of allergies linked to food, skin, dust, eye, insect-sting, drug, and eczema.
- On 10th June, 2022, to identify widespread allergies worldwide, Oncological has introduced the Allergy focus test. Users can learn which common allergies from around the world cause their body to react by taking the new Allergy focus test. For accurate diagnosis, it offers a thorough, personalized antibody profile of a patient's allergic triggers.
- On 22nd August, 2022, Reacta obtains a US patent for the diagnosis of food allergies. Challenge meals, which are used in oral food challenges, have received a patent (OFCs). Reacta's formulation enables the creation of non-allergen formulations that taste and feel identical to those that include allergens.
According to the study, key players dominating the global allergy diagnostics market are AstraBiotech (Germany), ACON Laboratories (U.S), Compagnie Merieux Alliance SAS (France), Danaher Corporation (U.S), Eurofins Scientific (France), Hollisterstier Allergy (U.S), HOB Biotech (China), Lincoln Diagnostics (U.S), Minares Medical (U.S), Neogen (U.S), Omega Diagnostics Group (U.K), Romer Labs (Austria), Thermo Fisher Scientific (U.S), Siemens (Germany), among others.
Browse the full report at https://www.sheeranalyticsandinsights.com/market-report-research/allergy-diagnostics-market-21
The Global Allergy Diagnostics Market Has Been Segmented Into:
The Global Allergy Diagnostics Market – by Product Type:
- Consumables
- Instruments
- Fungal Allergy Diagnostics
- Neutral Lactase
- Services
The Global Allergy Diagnostics Market – by Allergen Type:
- Inhaled Allergens
- Drug Allergens
- Food Allergens
- Other Allergens
The Global Allergy Diagnostics Market – by End-User:
- Diagnostic Laboratories
- Academic Research Institutes
- Hospital Sectors
- Others
The Global Allergy Diagnostics Market – by Regions:
- North America
- The U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia
- Rest of Asia Pacific
- LAMEA
- Middle East
- Saudi Arabia
- UAE
- Others
- Latin America
- Brazil
- Chile
- Others
- Africa
- South Africa
- Egypt
- Others
No comments:
Post a Comment